Back

Notification report

Full notification file


General information

Notification Number
B/DE/11/PEI1393

Member State to which the notification was sent
Germany

Date of acknowledgement from the Member State Competent Authority
27/06/2011

Title of the Project
VXM01 phase I dose escalation study in patients with locally advanced, inoperable and stage IV pancreatic cancer to examine safety, tolerability, and immune response to the investigational VEGFR-2 DNA vaccine VXM01

Proposed period of release:
01/11/2011 to 30/10/2012

Name of the Institute(s) or Company(ies)
VAXIMM GmbH, MAFINEX-Technologiezentrum
Julius-Hatry-Straße 1
68163 Mannheim;


3. Is the same GMO release planned elsewhere in the Community?
No

Has the same GMO been notified elsewhere by the same notifier?
No

GMO characterization

GMO is a:
Bacterium

Identity of the GMO:
Proteobacteria, Gammaproteobacteria

Information relating to the recipient or parental organisms from wich the GMO is derived

Common Name	Genus	Species	Subspecies	Strain	Pathovar
S. Typhi	Enterobacteriaceae	salmonella	enterica	Ty21a	Serotype Typhi

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known